Sonex Health
Kari Cierzan has a diverse work experience in various roles and industries. Kari started their career at Boston Scientific as an Upstream Product Manager in 2003 and then moved on to work at St. Jude Medical as a Global Marketing Manager from 2004 to 2006. Kari continued their career at American Medical Systems as a Senior Product Manager from 2006 to 2011. Kari then joined Honeywell as a Senior Global Product Marketing Manager for Speed & Position in 2011. In 2012, they became the Director of Marketing at NxThera, which was later acquired by Boston Scientific. Kari worked as a Principal Product Manager at Boston Scientific from 2018 to 2019. Kari simultaneously pursued their Master of Science in Nursing degree as a student at St. Catherine University from 2018 to 2020. After completing their degree, they worked as a Registered Nurse at Hennepin Healthcare from 2020 to 2022. Currently, they hold the positions of Director of Marketing and Senior Director of Marketing at Sonex Health, starting in 2021.
Kari Cierzan earned a Master of Science - MS degree in Registered Nursing/Registered Nurse from St. Catherine University, which they completed from 2018 to 2020. Kari also holds a Bachelor of Arts - BA degree in Russian Language, International Relations from the University of Wisconsin-Madison. Additionally, Kari Cierzan pursued a Master of Business Administration - MBA degree with a focus on Marketing from the University of St. Thomas, although the specific duration of this program is not provided.
This person is not in any offices
Sonex Health
Sonex Health reduces invasiveness, improves safety, and lowers the cost of care through transformative ultrasound.“Refined simplicity” is the guiding principle behind Sonex Health. To drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians DarrylBarnes, MD and Jay Smith, MD, and business operations expert Aaron Keenan founded Sonex Health in 2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs.The ultra-low-profile SX-One MicroKnife with Meerkat Technology is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives.